TGen develops processing procedures for ‘single-cell’ sequencing
PHOENIX, Ariz. -- Oct. 16, 2017 -- The Translational Genomics Research Institute (TGen) today announced grant support from the Chan Zuckerberg Initiative (CZI) donor advised...
NEWS INDEX
Therapeutic form of arsenic is a potential treatment for deadly type of brain cancer
PHOENIX, Ariz. -- Oct. 17, 2017 -- From Sherlock Holmes to Agatha Christie, arsenic is often the poison of choice in popular whodunits. But in...
New bowel cancer drug target discovered
Researchers at the Francis Crick Institute have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic...
Three of the most deadly cancers get critical funding for research
Credit: Fred Hutch News Services Immunotherapy for leukemia patients has been nothing short of a miracle. Now scientists hope to use that science and other...
Researchers release the brakes on the immune system
Credit: (c) Photo: Volker Lannert/Uni Bonn Many tumors possess mechanisms to avoid destruction by the immune system. For instance, they misuse the natural "brakes" in...
Breast cancer treatments today — and tomorrow (video)
Credit: The American Chemical Society AMES, Iowa - The concept of "collective intelligence" is simple - it asserts that if a team performs well on...
A new compound targets energy generation, thereby killing metastatic cells
Cancer can most often be successfully treated when confined to one organ. But a greater challenge lies in treating cancer that has metastasized, or spread,...
UB spinoff company For-Robin moves one step closer to human clinical trials
Credit: Credit: Loukia Karacosta/For-Robin Inc. BUFFALO, N.Y. -- Scientists from For-Robin Inc., a University at Buffalo biotechnology spinoff, have published new scientific results showing that...
Biopsy specimen found to be reliable for evaluating DLL3 expression in small cell lung cancer
Yokohama, Japan - Oct. 17, 2017 - Small cell lung cancer (SCLC) biopsy specimen was found to be reliable material for evaluating DLL3 expression; high...
Treatment based On BRCA1 level does not increase survival of stage II/III NSCLC N+ resected patients
Yokohama, Japan - Oct. 17, 2017 - New research shows that treating stage II and III non-small cell lung cancer (NSCLC) N+ resected patients with...
JAX, Seven Bridges to build centralized data platform to advance cancer research
The Jackson Laboratory (JAX), a nonprofit biomedical research institution, and Seven Bridges, the leading biomedical data analysis company, today announced a new collaboration to build...
Researchers confirm IASLC characterization of uncertain R status with prognosis between R0 and R1
Yokohama, Japan - Oct. 17, 2017 - The findings of a recent study confirm the International Association for the Study of Lung Cancer (IASLC)'s proposed...
Cleveland clinic study: Timing of melanoma diagnosis, treatment critical to survival
EMBARGOED UNTIL 9 a.m. ET Tuesday, Oct. 17, 2017, CLEVELAND: A new Cleveland Clinic study underscores the importance of early detection and treatment of melanoma,...
Genomics researchers showcase their applications of Droplet Digital PCR at ASHG 2017 Annual Meeting
ORLANDO, Fla. - Oct. 17, 2017 - The sensitivity and reliability of Droplet Digital PCR will be showcased in over a dozen presentations at the...
Many pelvic tumors in women may have common origin — fallopian tubes
Most - and possibly all - ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them. This is the finding...
